AVD AMERICAN VANGUARD CORP
Agricultural Chemicals · NYSE · SEC CIK 5981 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.8%
TTM net income YoY46.6%
TTM EPS YoY47.5%
Revenue 3-yr CAGR-4.2%
Net income 3-yr CAGR—
Margins
Gross margin28.4%
Operating margin-5.7%
Net margin-12.0%
FCF margin-2.5%
EBITDA margin-5.8%
Returns
ROE-31.2%
ROA-9.1%
ROIC (approx.)-6.1%
Asset turnover0.76x
Leverage & solvency
Liabilities / assets75.4%
Debt / equity1.64x
Current ratio2.02x
Interest coverage-0.96x
Cash quality & payout
Operating cash flow / net income0.11x
Accruals ratio-8.1%
Payout ratio—
Capex / revenue1.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $515.11M | $547.31M |
| Cost of revenue | $367.55M | $426.99M |
| Gross profit | $147.56M | $120.32M |
| R&D expense | $23.16M | $32.66M |
| SG&A expense | $110.63M | $119.63M |
| Operating income | -$28.30M | -$101.56M |
| Interest expense | $18.47M | $16.55M |
| Pretax income | -$47.20M | -$120.46M |
| Income tax | $2.68M | $5.88M |
| Net income | -$49.88M | -$126.34M |
| EBITDA | -$23.04M | -$96.40M |
| EPS (basic) | -1.75 | -4.50 |
| EPS (diluted) | -1.75 | -4.50 |
| Dividends declared per share | — | 0.06 |
| Weighted avg. shares (diluted) | 28.43M | 28.06M |
| Balance sheet | ||
| Cash & equivalents | $12.43M | $12.51M |
| Receivables | $160.51M | $169.74M |
| Inventory | $176.03M | $179.29M |
| Current assets | $370.52M | $378.89M |
| PP&E, net | $53.04M | $58.17M |
| Goodwill | $0 | $19.70M |
| Intangibles | $138.75M | $150.50M |
| Total assets | $596.54M | $636.72M |
| Current liabilities | $209.45M | $232.35M |
| Short-term debt | $0 | $0 |
| Long-term debt | $174.00M | $147.33M |
| Total debt | $174.00M | $147.33M |
| Total liabilities | $404.14M | $403.61M |
| Shareholders' equity | $192.40M | $233.11M |
| Net debt | $161.57M | $134.82M |
| Cash flow statement | ||
| Operating cash flow | -$21.19M | $3.92M |
| Capital expenditure | $3.92M | $7.28M |
| Free cash flow | -$25.11M | -$3.36M |
| Investing cash flow | -$3.61M | -$6.62M |
| Financing cash flow | $23.70M | $4.54M |
| Depreciation & amortization | $5.25M | $5.16M |
| Stock-based compensation | $2.02M | $4.41M |
| Dividends paid | $0 | $2.51M |
| Share buybacks | $0 | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.